Showing results (641-650 of 738) with videos related to
Sort By:
Pageof 74
Alimentary Pharmacology & Therapeutics|August 21, 2013
Diagnostic accuracy of faecal immunochemical test for screening individuals with a family history of colorectal cancerS C Ng, J Y L Ching, V Chan, et al.British Journal of Anaesthesia|September 1, 2021
Anaesthetic depth and delirium after major surgery: a randomised clinical trialLisbeth A Evered, Matthew T V Chan, Ruquan Han, et al.Respiratory Medicine|July 12, 2003
A multicenter phase II study of the efficacy and safety of docetaxel plus cisplatin in Asian chemonaïve patients with metastatic or locally advanced non-small cell lung cancerJames C M Ho, E H Tan, S S Leong, et al.Plos One|May 27, 2026
Effects of taurine supplementation on metabolic health and biological aging in healthcare workers: A protocol for a triple-blinded, Bayesian-optimized phase II randomized controlled trialMandy H M Chu, Jacky K M Lai, Anna Lee, et al.BJA Open|February 20, 2026
Sugammadex, neostigmine, and postoperative pulmonary complications: protocol of the SNaPP multicentre randomised controlled trialKate Leslie, Sabine Braat, Jai N Darvall, et al.Translational Psychiatry|October 25, 2018
Developmental protein kinase C hyper-activation results in microcephaly and behavioral abnormalities in zebrafishTaian Liu, Yujian Shi, Matthew T V Chan, et al.Journal of Cellular and Molecular Medicine|April 12, 2019
The phytochemical polydatin ameliorates non-alcoholic steatohepatitis by restoring lysosomal function and autophagic fluxXiaoting Chen, Hung Chan, Lin Zhang, et al.Theranostics|March 21, 2018
Genomic analysis of liver cancer unveils novel driver genes and distinct prognostic featuresXiangchun Li, Weiqi Xu, Wei Kang, et al.BMJ Open|September 1, 2019
Balance of benefits and harms of different blood pressure targets in people with multiple chronic conditions: a quantitative benefit-harm assessmentHélène E Aschmann, Cynthia M Boyd, Craig W Robbins, et al.Journal of the American College of Cardiology|October 17, 2009
Is a pre-operative brain natriuretic peptide or N-terminal pro-B-type natriuretic peptide measurement an independent predictor of adverse cardiovascular outcomes within 30 days of noncardiac surgery? A systematic review and meta-analysis of observational studiesGanesan Karthikeyan, Ross A Moncur, Oren Levine, et al.Pageof 74